SURYA P BHATT

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “TARGETED LUNG DENERVATION IN COPD: OUTCOMES FROM THE AIRFLOW-3 OPEN LABEL COHORT”.

TARGETED LUNG DENERVATION IN COPD: OUTCOMES FROM THE AIRFLOW-3 OPEN LABEL COHORT

CHEST Journal(2024)10.1016/j.chest.2024.07.078

N/A

0DataRank · unranked

2 citations

Richard Sue, Carla Lamb, Jose M. Soto Soto, B. Petkovich, Lisa Kopas +7 more

COPD EXACERBATIONS HAVE LESS IMPACT ON LUNG FUNCTION DURING DUPILUMAB TREATMENT: POOLED ANALYSIS FROM BOREAS AND NOTUS

CHEST Journal(2025)10.1016/j.chest.2025.09.079

N/A

0DataRank · unranked

0 citations

Christopher E. Brightling, Francesca Puggioni, SURYA P BHATT, KLAUS F RABE, Jinping Zheng +5 more

RAPID PATIENT-REPORTED SYMPTOM IMPROVEMENT WITH DUPILUMAB IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: POOLED DATA FROM THE BOREAS AND NOTUS TRIALS

CHEST Journal(2025)10.1016/j.chest.2025.07.3083

N/A

0DataRank · unranked

0 citations

SURYA P BHATT, Dave Singh, GUY G BRUSSELLE, Ashraf Alzaabi, Nayia Petousi +5 more

EFFECT OF DUPILUMAB ON SYSTEMIC CORTICOSTEROID AND ANTIBIOTIC USE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND TYPE 2 INFLAMMATION

CHEST Journal(2025)10.1016/j.chest.2025.07.3079

N/A

0DataRank · unranked

0 citations

ANTONIO R ANZUETO, Jean Bourbeau, Alberto Papi, SURYA P BHATT, Stephanie Korn +7 more